These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25102041)

  • 1. Clinicians' perspective on the use of immunoassay versus definitive laboratory quantitation methodologies for medication monitoring.
    McCarberg BH; Kirsh KL; Passik SD
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):255-8. PubMed ID: 25102041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoassay in healthcare testing applications.
    DePriest AZ; Black DL; Robert TA
    J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine and oral fluid drug testing in support of pain management.
    Kwong TC; Magnani B; Moore C
    Crit Rev Clin Lab Sci; 2017 Sep; 54(6):433-445. PubMed ID: 28990451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory monitoring of OxyContin (oxycodone): clinical pitfalls.
    Von Seggern RL; Fitzgerald CP; Adelman LC; Adelman JU
    Headache; 2004 Jan; 44(1):44-7. PubMed ID: 14979882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.
    Argoff CE; Alford DP; Fudin J; Adler JA; Bair MJ; Dart RC; Gandolfi R; McCarberg BH; Stanos SP; Gudin JA; Polomano RC; Webster LR
    Pain Med; 2018 Jan; 19(1):97-117. PubMed ID: 29206984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Urine Drug Testing in the Current Opioid Epidemic.
    Mahajan G
    Anesth Analg; 2017 Dec; 125(6):2094-2104. PubMed ID: 29189366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug testing for pain management.
    Magnani B; Kwong T
    Clin Lab Med; 2012 Sep; 32(3):379-90. PubMed ID: 22939297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.
    McCarberg BH
    Postgrad Med; 2011 Nov; 123(6):124-31. PubMed ID: 22104461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using urine drug testing to support healthy boundaries in clinical care.
    Heit HA; Gourlay DL
    J Opioid Manag; 2015; 11(1):7-12. PubMed ID: 25750160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of urine toxicology in chronic opioid analgesic therapy.
    Compton P
    Pain Manag Nurs; 2007 Dec; 8(4):166-72. PubMed ID: 18036504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug testing and adherence monitoring in pain management: Oral fluid testing.
    Moore C
    J Opioid Manag; 2015; 11(1):69-75. PubMed ID: 25750167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.
    McMillin GA; Slawson MH; Marin SJ; Johnson-Davis KL
    J Pain Palliat Care Pharmacother; 2013 Dec; 27(4):322-39. PubMed ID: 24147959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing urine drug testing for monitoring medication compliance in pain management.
    Melanson SE; Ptolemy AS; Wasan AD
    Pain Med; 2013 Dec; 14(12):1813-20. PubMed ID: 23899241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.